165 related articles for article (PubMed ID: 23664488)
1. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
[TBL] [Abstract][Full Text] [Related]
3. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
[TBL] [Abstract][Full Text] [Related]
5. Histogenesis of metaplastic breast carcinoma and axillary nodal metastases.
Osako T; Horii R; Ogiya A; Iijima K; Iwase T; Akiyama F
Pathol Int; 2009 Feb; 59(2):116-20. PubMed ID: 19154267
[TBL] [Abstract][Full Text] [Related]
6. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.
Matuszczak E; Tylicka M; Komarowska MD; Debek W; Hermanowicz A
Cell Biochem Funct; 2020 Jul; 38(5):533-540. PubMed ID: 32207552
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
10. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
[TBL] [Abstract][Full Text] [Related]
11. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
Fan LC; Jeng YM; Lu YT; Lien HC
PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
Zhang Y; Ding J; Zhang X; Hua K
J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
[TBL] [Abstract][Full Text] [Related]
14. Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia.
Lien HC; Lee YH; Juang YL; Lu YT
Pathology; 2019 Jun; 51(4):375-383. PubMed ID: 31010590
[TBL] [Abstract][Full Text] [Related]
15. UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Mondal M; Conole D; Nautiyal J; Tate EW
Br J Cancer; 2022 Jan; 126(1):24-33. PubMed ID: 34497382
[TBL] [Abstract][Full Text] [Related]
16. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.
Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS
Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
18. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
[TBL] [Abstract][Full Text] [Related]
20. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
